These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9813052)

  • 61. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
    Schiemann WP; Graves LM; Baumann H; Morella KK; Gearing DP; Nielsen MD; Krebs EG; Nathanson NM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5361-5. PubMed ID: 7777512
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.
    Wu TR; Hong YK; Wang XD; Ling MY; Dragoi AM; Chung AS; Campbell AG; Han ZY; Feng GS; Chin YE
    J Biol Chem; 2002 Dec; 277(49):47572-80. PubMed ID: 12270932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. STAT 1 binds to the LPL promoter in vitro.
    Hogan JC; Stephens JM
    Biochem Biophys Res Commun; 2003 Jul; 307(2):350-4. PubMed ID: 12859963
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tyrosine kinase-mediated cell signalling in the activation of Mytilus hemocytes: possible role of STAT-like proteins.
    Canesi L; Betti M; Ciacci C; Citterio B; Pruzzo C; Gallo G
    Biol Cell; 2003 Dec; 95(9):603-13. PubMed ID: 14720463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
    Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
    EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation.
    Ram PA; Park SH; Choi HK; Waxman DJ
    J Biol Chem; 1996 Mar; 271(10):5929-40. PubMed ID: 8621467
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells.
    Bartoli M; Gu X; Tsai NT; Venema RC; Brooks SE; Marrero MB; Caldwell RB
    J Biol Chem; 2000 Oct; 275(43):33189-92. PubMed ID: 10961983
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
    Kunisada K; Tone E; Fujio Y; Matsui H; Yamauchi-Takihara K; Kishimoto T
    Circulation; 1998 Jul; 98(4):346-52. PubMed ID: 9711940
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer.
    Yin T; Yasukawa K; Taga T; Kishimoto T; Yang YC
    Exp Hematol; 1994 May; 22(5):467-72. PubMed ID: 8174677
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
    Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
    J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells.
    Tanuma N; Nakamura K; Shima H; Kikuchi K
    J Biol Chem; 2000 Sep; 275(36):28216-21. PubMed ID: 10859312
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Members of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway are present and active in human sperm.
    D'Cruz OJ; Vassilev AO; Uckun FM
    Fertil Steril; 2001 Aug; 76(2):258-66. PubMed ID: 11476770
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
    Li WQ; Dehnade F; Zafarullah M
    J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
    [TBL] [Abstract][Full Text] [Related]  

  • 76. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
    Freeth JS; Silva CM; Whatmore AJ; Clayton PE
    Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1.
    Xu J; Ji S; Venable DY; Franklin JL; Messina JL
    J Endocrinol; 2005 Mar; 184(3):481-92. PubMed ID: 15749807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13.
    Faffe DS; Flynt L; Mellema M; Moore PE; Silverman ES; Subramaniam V; Jones MR; Mizgerd JP; Whitehead T; Imrich A; Panettieri RA; Shore SA
    J Allergy Clin Immunol; 2005 Mar; 115(3):514-20. PubMed ID: 15753898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.